Extreme Drug Resistance for Testicular Cancer
Learn More About Testicular Cancer Extreme Drug Resistance: Chat with Us | Email Us
One of the innovative ways Cancer Treatment Centers of America tailors a treatment plan for each individual is by using the Extreme Drug Resistance (EDR) Assay (or Chemoresistance). The EDR is a highly accurate test for solid tumors, which determines the probability of a tumor’s resistance to specific chemotherapeutic drugs. If the tumor cells grow in the presence of extreme exposure to a drug, this indicates the presence of significant drug resistance. Therefore, if the tumor is resistant to a drug in this assay, then the tumor growing in a patient’s body will almost certainly be resistant to that drug. With this information, the CTCA physicians can avoid unnecessary toxicity, consider other treatment protocols, and minimize costs.